Source: Inflammopharmacology. Unidades: IB, ICB
Subjects: DOENÇAS AUTOIMUNES, SISTEMA NERVOSO CENTRAL, ESCLEROSE MÚLTIPLA, INFLAMAÇÃO, ENCEFALOMIELITE ANIMAL, PROLIFERAÇÃO CELULAR, FÁRMACOS
ABNT
OLIVEIRA, Daniel May de et al. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration. Inflammopharmacology, v. 23, n. 6, p. 343-354, 2015Tradução . . Disponível em: https://doi.org/10.1007/s10787-015-0252-1. Acesso em: 21 ago. 2024.APA
Oliveira, D. M. de, Oliveira, E. M. L. de, Ferrari, M. de F. R., Semedo, P., Hiyane, M. I., Cenedeze, M. A., et al. (2015). Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration. Inflammopharmacology, 23( 6), 343-354. doi:10.1007/s10787-015-0252-1NLM
Oliveira DM de, Oliveira EML de, Ferrari M de FR, Semedo P, Hiyane MI, Cenedeze MA, Pacheco-Silva A, Câmara NOS, Peron JPS. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration [Internet]. Inflammopharmacology. 2015 ; 23( 6): 343-354.[citado 2024 ago. 21 ] Available from: https://doi.org/10.1007/s10787-015-0252-1Vancouver
Oliveira DM de, Oliveira EML de, Ferrari M de FR, Semedo P, Hiyane MI, Cenedeze MA, Pacheco-Silva A, Câmara NOS, Peron JPS. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration [Internet]. Inflammopharmacology. 2015 ; 23( 6): 343-354.[citado 2024 ago. 21 ] Available from: https://doi.org/10.1007/s10787-015-0252-1